1Rush Cancer Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612-3515, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Myelodysplastic syndromes (MDS) patients with higher bone marrow Tumor Necrosis Factor-alpha (TNF-alpha) levels responded better to pentoxifylline and ciprofloxacin (PC) therapy. This PC therapy effectively reduced TNF-alpha levels over time.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: